drugset / Trial / NCT06377982

Human Umbilical Cord Blood Infusion in Patients with Cerebral Palsy

NCT06377982 ↗

Phase 1 Not yet recruiting 12 enrolled StemCyte International, Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

A phase I, randomized, double-blind, placebo-controlled clinical study to assess the safety and efficacy of allogeneic human umbilical cord blood infusion in children with cerebral palsy

Timeline

Start
2025-09
Primary completion
2027-09
Completion
2028-12

Drugs

EvaluationDrugModalityDoseRoute
Subject hUCB Cell therapy — —

Indications